PBSV supply chain intelligence for Pharma-Bio Serv, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Pharma-Bio Serv, Inc. (PBSV) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| GLOBAL-GROUPS-OF-AFFILIATED-COMPANIES | GLOBAL-GROUPS-OF-AFFILIATED-COMPANIES | 92% | During the three months ended January 31, 2026, aggregate revenues from these global groups of affiliated companies were 16.1 %, 15.5 %, 15.0 % and 0.0 %, or a total of 46.6 % |
| THREE-GROUPS-OF-AFFILIATED-COMPANIES | THREE-GROUPS-OF-AFFILIATED-COMPANIES | 92% | At the global level three groups of affiliated companies accounted for 10% or more of our revenues in either October 31, 2024 or 2023. |
| SCIENZA-LABS-INC | SCIENZA-LABS-INC | 62% | r assets ( 21,595 ) ( 105,132 ) Decrease in liabilities ( 1,207,329 ) ( 326,662 ) NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES ( 566,701 ) 1,890,960 CASH FLOWS FROM INVESTING ACTIVITIES: Acquisit… |
| U-S-INVESTMENT-COMPANY | U-S-INVESTMENT-COMPANY | 62% | es (known as performance obligations) to its customers. Revenue for short term fixed fee contracts or “not to exceed” contracts is recognized similarly, except that certain milestones also must be re… |